- Corporate Officers - F
- Farrell Peter C
Insider Trading History of Farrell Peter C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Farrell Peter C since 2015.
This trader's CIK number is 1186102.
At the time of last reporting, Farrell Peter C was the Director of Resmed Inc. (stock ticker symbol RMD).
Also see all insider trading activities at Resmed Inc.
Note that in the past
FARRELL PETER C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nuvasive Inc (NUVA) by Farrell Peter C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | NUVA | 0 | $0 | 0 | $0 | 22,844 | $450,597 |
2016 | NUVA | 0 | $0 | 0 | $0 | 20,000 | $399,950 |
Yearly summary of insider trading at Evolus, Inc. (EOLS) by Farrell Peter C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | EOLS | 10,000 | $91,050 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arcturus Therapeutics Holdings Inc. (ARCT) by Farrell Peter C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | ARCT | 0 | $0 | 0 | $0 | 3,131 | $0 |
2019 | ARCT | 9,113 | $99,671 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Resmed Inc (RMD) by Farrell Peter C
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | RMD | 0 | $0 | 8,945 | $2,105,058 | 0 | $0 |
2024 | RMD | 0 | $0 | 31,535 | $6,928,789 | 0 | $0 |
2022 | RMD | 0 | $0 | 18,100 | $4,017,746 | 0 | $0 |
2017 | RMD | 0 | $0 | 338,392 | $25,869,277 | 338,392 | $11,269,701 |
2016 | RMD | 0 | $0 | 419,980 | $24,866,012 | 280,000 | $7,912,800 |
2015 | RMD | 0 | $0 | 351,169 | $20,885,375 | 353,169 | $6,324,793 |
Insider trading activities at 4 companies by Farrell Peter C:
1. Nuvasive Inc (NUVA)
2. Evolus, Inc. (EOLS)
3. Arcturus Therapeutics Holdings Inc. (ARCT)
4. Resmed Inc (RMD)
Table 1. Insider trading of Nuvasive Inc (NUVA) by Farrell Peter C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-05-03 | NUVA | Option Ex | 22,844 | 19.73 | 450,597 |
2016-10-31 | NUVA | Option Ex | 6,000 | 25.30 | 151,800 |
2016-02-18 | NUVA | Option Ex | 14,000 | 17.73 | 248,150 |
Table 2. Insider trading of Evolus, Inc. (EOLS) by Farrell Peter C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-09-06 | EOLS | Buy | 10,000 | 9.11 | 91,050 |
Table 3. Insider trading of Arcturus Therapeutics Holdings Inc. (ARCT) by Farrell Peter C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-06-14 | ARCT | Option Ex | 3,131 | .00 | 0 |
2019-08-19 | ARCT | Buy | 4,681 | 11.02 | 51,584 |
2019-08-20 | ARCT | Buy | 4,432 | 10.85 | 48,087 |
Table 4. Insider trading of Resmed Inc (RMD) by Farrell Peter C
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-07-02 | RMD | Sale | 945 | 255.49 | 241,438 |
2025-05-07 | RMD | Sale | 2,000 | 242.25 | 484,500 |
2025-04-02 | RMD | Sale | 2,000 | 219.74 | 439,480 |
2025-03-05 | RMD | Sale | 2,000 | 227.71 | 455,420 |
2025-02-05 | RMD | Sale | 2,000 | 242.11 | 484,220 |
2024-12-04 | RMD | Sale | 2,000 | 245.65 | 491,300 |
2024-11-06 | RMD | Sale | 2,000 | 248.74 | 497,480 |
2024-10-02 | RMD | Sale | 2,000 | 237.20 | 474,400 |
2024-09-04 | RMD | Sale | 2,000 | 239.90 | 479,800 |
2024-02-22 | RMD | Sale | 10,935 | 182.66 | 1,997,430 |
2023-05-03 | RMD | Sale | 12,600 | 237.17 | 2,988,379 |
2022-10-31 | RMD | Sale | 9,050 | 221.97 | 2,008,873 |
2022-10-31 | RMD | Sale | 9,050 | 221.97 | 2,008,873 |
2017-11-09 | RMD | Option Ex | 118,392 | 41.35 | 4,896,101 |
2017-11-09 | RMD | Sale | 118,392 | 82.70 | 9,791,018 |
2017-11-06 | RMD | Sale | 20,000 | 83.66 | 1,673,140 |
2017-11-06 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-10-04 | RMD | Sale | 20,000 | 77.01 | 1,540,200 |
2017-10-04 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-09-05 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-09-05 | RMD | Sale | 20,000 | 77.06 | 1,541,100 |
2017-08-04 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-08-04 | RMD | Sale | 20,000 | 75.15 | 1,503,000 |
2017-07-05 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-07-05 | RMD | Sale | 20,000 | 76.82 | 1,536,399 |
2017-06-05 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-06-05 | RMD | Sale | 20,000 | 72.65 | 1,452,960 |
2017-05-04 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-05-04 | RMD | Sale | 20,000 | 68.75 | 1,374,920 |
2017-04-04 | RMD | Sale | 20,000 | 70.67 | 1,413,360 |
2017-04-04 | RMD | Option Ex | 20,000 | 27.58 | 551,600 |
2017-03-06 | RMD | Sale | 20,000 | 71.70 | 1,434,000 |
2017-03-06 | RMD | Option Ex | 20,000 | 30.64 | 612,800 |
2017-02-06 | RMD | Option Ex | 20,000 | 33.70 | 674,000 |
2017-02-06 | RMD | Sale | 20,000 | 68.32 | 1,366,420 |
2017-01-04 | RMD | Sale | 20,000 | 62.14 | 1,242,760 |
2017-01-04 | RMD | Option Ex | 20,000 | 33.70 | 674,000 |
2016-12-05 | RMD | Option Ex | 20,000 | 33.70 | 674,000 |
2016-12-05 | RMD | Sale | 20,000 | 59.83 | 1,196,540 |
2016-12-05 | RMD | Option Ex | 20,000 | 33.70 | 674,000 |
2016-12-05 | RMD | Sale | 20,000 | 59.83 | 1,196,540 |
2016-12-05 | RMD | Option Ex | 20,000 | 33.70 | 674,000 |
2016-12-05 | RMD | Sale | 20,000 | 59.83 | 1,196,540 |
2016-11-04 | RMD | Sale | 20,000 | 57.28 | 1,145,560 |
2016-11-04 | RMD | Option Ex | 20,000 | 33.70 | 674,000 |
2016-10-04 | RMD | Option Ex | 20,000 | 30.98 | 619,600 |
2016-10-04 | RMD | Sale | 20,000 | 64.70 | 1,293,959 |
2016-09-06 | RMD | Sale | 20,000 | 67.29 | 1,345,760 |
2016-09-06 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-08-04 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-08-04 | RMD | Sale | 20,000 | 69.16 | 1,383,260 |
2016-07-05 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-07-07 | RMD | Sale | 20,000 | 63.62 | 1,272,400 |
2016-06-06 | RMD | Sale | 20,000 | 59.82 | 1,196,400 |
2016-06-06 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-05-04 | RMD | Sale | 20,000 | 55.90 | 1,118,000 |
2016-05-04 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-04-04 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-04-04 | RMD | Sale | 20,000 | 57.51 | 1,150,200 |
2016-03-04 | RMD | Sale | 20,000 | 57.51 | 1,150,200 |
2016-03-04 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-02-25 | RMD | Sale | 139,980 | 57.31 | 8,022,253 |
2016-02-04 | RMD | Sale | 20,000 | 57.70 | 1,154,000 |
2016-02-04 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-01-04 | RMD | Option Ex | 20,000 | 25.54 | 510,800 |
2016-01-04 | RMD | Sale | 20,000 | 52.22 | 1,044,400 |
2015-10-01 | RMD | Option Ex | 27,169 | 19.25 | 523,003 |
2015-10-01 | RMD | Sale | 27,169 | 50.93 | 1,383,635 |
2015-09-01 | RMD | Sale | 36,000 | 50.82 | 1,829,592 |
2015-09-01 | RMD | Option Ex | 36,000 | 19.25 | 693,000 |
2015-08-03 | RMD | Option Ex | 36,000 | 19.25 | 693,000 |
2015-08-03 | RMD | Sale | 36,000 | 56.37 | 2,029,140 |
2015-07-01 | RMD | Option Ex | 36,000 | 19.25 | 693,000 |
2015-07-01 | RMD | Sale | 36,000 | 55.99 | 2,015,532 |
2015-06-01 | RMD | Option Ex | 36,000 | 19.25 | 693,000 |
2015-06-01 | RMD | Sale | 36,000 | 59.25 | 2,132,856 |
2015-05-01 | RMD | Option Ex | 36,000 | 19.25 | 693,000 |
2015-05-01 | RMD | Sale | 36,000 | 64.56 | 2,324,232 |
2015-04-01 | RMD | Option Ex | 38,000 | 17.39 | 660,630 |
2015-04-01 | RMD | Sale | 36,000 | 70.97 | 2,555,100 |
2015-03-02 | RMD | Sale | 36,000 | 64.64 | 2,326,860 |
2015-03-02 | RMD | Option Ex | 36,000 | 15.52 | 558,720 |
2015-02-02 | RMD | Sale | 36,000 | 62.13 | 2,236,788 |
2015-02-02 | RMD | Option Ex | 36,000 | 15.52 | 558,720 |
2015-01-02 | RMD | Option Ex | 36,000 | 15.52 | 558,720 |
2015-01-02 | RMD | Sale | 36,000 | 56.99 | 2,051,640 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Farrell Peter C
(Director of Resmed Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.